Kyoji Tsuchikama

17PUBLICATIONS
46CO-AUTHORS
Biologically active moleculesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 01, 2026
Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics.

|Apr 14, 2026
Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugates.

Aiko Yamaguchi, Junping Hong, Leike Li

|Jan 27, 2026
Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer.

Dileep Reddy Rampa, Minji Seo, Nanae Ogata

|Mar 07, 2025
177Lu-Labeled Antibody-Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors.

Aiko Yamaguchi, Chisato M Yamazaki, Yasuaki Anami

|Dec 18, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton C High

|Nov 28, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton High

Pageof 3

Frequent Collaborators

10 joint publications

Yasuaki Anami

6 joint publications

Chisato M Yamazaki

6 joint publications

Zhiqiang An

6 joint publications

Ningyan Zhang